AD Cure Pharma

Ozim 20 mg Tablet contains Olanzapine, an atypical antipsychotic used to treat schizophrenia, bipolar disorder, and as adjunct therapy in treatment-resistant depression
It works by modulating dopamine and serotonin receptors, stabilizing mood, reducing hallucinations, delusions, and improving thought clarity

Halo 0.25 mg Tablet contains Haloperidol, a high‑potency first‑generation antipsychotic used in low doses for acute psychosis, Tourette’s syndrome, or severe agitation. At 0.25 mg, the dose is considered very low—often used for sensitive patients or to initiate therapy
It acts by blocking dopamine D₂ receptors, helping reduce hallucinations and agitation. Common side effects include extrapyramidal symptoms such as akathisia, dystonia, parkinsonism, as well as drowsiness, dizziness, insomnia, and nausea

Emipride 50 mg Tablet contains Amisulpride, an atypical antipsychotic primarily used to manage schizophrenia and dysthymia. Amisulpride works by selectively blocking dopamine D₂ and D₃ receptors in the brain, helping to normalize dopamine levels and alleviate both positive symptoms (e.g., hallucinations, delusions) and negative symptoms (e.g., emotional withdrawal, apathy) associated with these conditions. The typical dosage ranges from 50 mg to 300 mg per day, depending on the severity of symptoms and individual response. Common side effects may include drowsiness, weight gain, constipation, and increased prolactin levels, which can lead to breast enlargement or menstrual disturbances. Serious side effects, though rare, may include extrapyramidal symptoms (e.g., tremors, rigidity), QT interval prolongation, and neuroleptic malignant syndrome. Patients should be monitored regularly, especially during the initial stages of treatment or when doses are adjusted. Amisulpride should be used with caution in individuals with a history of cardiovascular disease, liver or kidney disorders, and those who are pregnant or breastfeeding. It is important to follow the prescribed dosage and consult a healthcare provider before starting or discontinuing

Emipride 400 mg contains Amisulpride, an atypical benzamide antipsychotic used to manage acute and chronic schizophrenia, particularly with positive symptoms, at doses of 400–800 mg/day, up to 1200 mg in severe cases
Lower dosing (50–300 mg/day) may benefit negative symptoms or depressive disorders It acts by antagonizing dopamine D₂/D₃ receptors and serotonin 5‑HT₂B/5‑HT₇ receptors, with antidepressant potential via dopamine autoreceptor blockade at low doses